(Q42849622)

8 November 2017

Genetic polymorphisms and individualized tacrolimus dosing (English)

1 reference

8 November 2017

M A López-Montenegro Soria

1

1 reference

8 November 2017

J Kanter Berga

2

1 reference

8 November 2017

S Beltrán Catalán

3

1 reference

8 November 2017

J Milara Payá

4

1 reference

8 November 2017

L M Pallardó Mateu

5

1 reference

8 November 2017

N V Jiménez Torres

6

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Transplantation Proceedings

8 November 2017

1 reference

8 November 2017

42

1 reference

8 November 2017

8

1 reference

8 November 2017

3031-3033

1 reference

Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

8 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

Clinical impact of polymorphisms of transport proteins and enzymes involved in the metabolism of immunosuppressive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.08.001

10.1016/J.TRANSPROCEED.2010.08.001

7 January 2021

Identifiers

DOI

1 reference

8 November 2017

1 reference